Company intelligence / Profile preview
Bio Eleven
Seoul, South Korea
- Ownership
- Private
- Employees
- ~80
- Development stage
- Other
01
Overview
Bio Eleven is a South Korean biotechnology company specializing in microbiome research and high-potency probiotic products. The company is widely recognized for its De Simone brand, which utilizes a clinically validated formulation of eight probiotic strains to manage gastrointestinal conditions such as irritable bowel syndrome and ulcerative colitis. In 2022, Bio Eleven was acquired by TiumBio, a clinical-stage biopharmaceutical company, to synergize microbiome expertise with drug development capabilities. Bio Eleven operates the Kim Seok-jin Probiotics Research Institute and offers Ttobak, a personalized health service that provides customized probiotic subscriptions based on individual gut microbiome analysis. The company continues to develop next-generation live biotherapeutic products targeting immune and inflammatory diseases.
- Therapeutic areas
- Gastroenterology
- Modalities
- Live biotherapeutic product therapyProbiotics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Actial FarmaceuticaVSL Pharmaceuticals
Beyond the preview
Go deeper on Bio Eleven.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio Eleven.